Precision Vaccinations News
Search
Inline CSS
Clinical Trials
Lab Tests
Subscribe
Trials
Labs
Subscribe
Home
Dengue
Flu
Measles
RSV
STD
Travel
Vaccines
Chikungunya
Fact checked by
Robert Carlson, MD
Mar 25
4 min read
Chikungunya Vaccine Approaches Phase 3 Study
Valneva VLA1553 vaccine is critical as the chikungunya virus is considered a public health threat
Chikungunya
Fact checked by
Robert Carlson, MD
Jan 14
4 min read
Chikungunya Vaccine Candidate To Begin Testing in Europe
Emergent BioSolutions’ CHIKV-VLP vaccine is being developed for the prevention of disease caused by a chikungunya virus infection
Tropical Diseases
Chikungunya
Fact checked by
Robert Carlson, MD
Jan 7
4 min read
Chikungunya Vaccine Is On The FDA’s Fast-Track
Chikungunya vaccine VLA1553 is a monovalent single dose live attenuated vaccine candidate
Chikungunya
Fact checked by
Robert Carlson, MD
Nov 22
4 min read
Chikungunya VLP Vaccine Candidate Reports Positive Dosing Results
Emergent BioSolutions CHIKV VLP vaccine candidate produced neutralizing antibody responses against the chikungunya virus in most patients within 7 days after vaccination
Tropical Diseases
Chikungunya
Fact checked by
Robert Carlson, MD
Nov 18
4 min read
Chikungunya Vaccine Candidate Delivered Excellent Study Results
Valneva chikungunya vaccine candidate VLA1553 was generally safe in all dose groups and the local tolerability profile was excellent
Chikungunya
Show more